Occult bacteraemia is uncommon in febrile infants who appear well, and close clinical follow-up is more appropriate than blood tests

Acta Paediatrica, International Journal of Paediatrics

Volumn 104, Issue 2, 2015, Pages e76-e81

  Hernandez Bou, Susanna ^a   Trenchs, Victoria ^a   Batlle, Astrid ^a   Gene, Amadeu ^a   Luaces, Carles ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

Emergency department; Fever without source; Infants; Occult bacteraemia; Pneumococcal conjugated vaccine

Indexed keywords

ANTIBIOTIC AGENT; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOOD ANALYSIS; BLOOD CULTURE; CHILD; COHORT ANALYSIS; DISEASE DURATION; EMERGENCY WARD; FEMALE; FEVER; FOLLOW UP; HUMAN; IMMUNIZATION; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; OCCULT BACTERAEMIA; PATHOGENESIS; PEDIATRIC HOSPITAL; PNEUMONIA; PRIORITY JOURNAL; RETROPHARYNGEAL ABSCESS; RETROSPECTIVE STUDY; SHOULDER ARTHRITIS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; URINARY TRACT INFECTION; BLOOD; COMPLICATION; EMERGENCY HEALTH SERVICE; MICROBIOLOGY; PRESCHOOL CHILD; SPAIN; STATISTICS AND NUMERICAL DATA;

BACTEREMIA; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; FEVER; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; SPAIN;

EID: 84921535288     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/apa.12852     Document Type: Article

References (27)

1. Alpern ER, Alessandrini EA, Bell LM, Shaw KN, McGowan KL,. Occult bacteraemia from a pediatric emergency department: current prevalence, time to detection and outcome. Pediatrics 2000; 106: 505-11.
2. Bandyopadhyay S, Bergholte J, Blackwell CD, Friedlander JR, Hennes H,. Risk of serious bacterial infection in children with fever without source in the post-Haemophilus influenzae era when antibiotics are reserved for culture-proven bacteraemia. Arch Pediatr Adolesc Med 2002; 156: 512-7.
3. Lee GM, Harper MB,. Risk of bacteriemia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med 1998; 152: 624-8.
4. Benito-Fernández J, Mintegi S, Pocheville-Gurutzeta I, Sánchez Etxaniz J, Gõmez Cortés B, Hernández Almaraz JL,. Pneumococcal bacteraemia in febrile infants presenting to the emergency department 8 years after the introduction of pneumococcal conjugate vaccine in the Basque Country of Spain. Pediatr Infect Dis J 2010; 29: 1142-4.
5. Bressan S, Berlese P, Mion T, Masiero S, Cavallaro A, Da Dalt L,. Bacteraemia in feverish children presenting to the emergency department: a retrospective study and literature review. Acta Paediatr 2012; 101: 271-7.
6. Sard B, Bailey MC, Vinci R,. An analysis of pediatric blood cultures in the postpneumococcal conjugate vaccine era in a community hospital emergency department. Pediatr Emerg Care 2006; 22: 295-300.
7. Stoll ML, Rubin LG,. Incidence of occult bacteraemia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a children's hospital emergency department and urgent care center. Arch Pediatr Adolesc Med 2004; 158: 671-5.
8. Waddle E, Jhaveri R,. Outcomes of febrile children without localising signs after pneumococcal conjugate vaccine. Arch Dis Child 2009; 94: 144-7.
9. Wilkinson M, Bulloch B, Smith M,. Prevalence of occult bacteraemia in children aged 3 to 36 months presenting to the emergency department with fever in the postpneumococcal conjugate vaccine era. Acad Emerg Med 2009; 16: 220-5.
10. Baraff LJ, Bass JW, Fleisher GR, Klein JO, McCracken GH Jr, Powell KR, et al. Practice guideline for the management of children and infants 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med 1993; 22: 1198-210.
11. Lee GM, Fleisher GR, Harper MB,. Management of febrile children in the age of the pneumococcal conjugate vaccine: a cost-effectiveness analysis. Pediatrics 2001; 108: 835-44.
12. NICE. Feverish illness in children: assessment and initial management in children younger than 5 years. CG160. London: National Institute for Health and Clinical Excellence, 2013. Available at: ttp:// www.nice.org.uk/guidance/cg160 (access on July 28, 2014).
13. Baraff LJ,. Management of infants and young children with fever without source. Pediatr Ann 2008; 37: 673-9.
14. Dieckmann RA, Brownstein D, Gausche-Hill M,. The pediatric assessment triangle: a novel approach for the rapid evaluation of children. Pediatr Emerg Care 2010; 26: 312-5.
15. Manzano S, Bailey B, Gervaix A, Cousineau J, Delvin E, Girodias J,. Markers for bacterial infection in children with fever without source. Arch Dis Child 2011; 96: 440-6.
16. Simon A, Lukacs S, Pauline Mendola P,. Emergency department laboratory evaluations of fever without source in children aged 3 to 36 months. Pediatrics 2011; 128: e1368-75.
17. Herz AM, Greenhow TL, Alcantara J, Hansen J, Baxter RP, Black SB, et al. Changing epidemiology of outpatient bacteraemia in 3 to 36 month-old children after the introduction of the heptavalent-conjugate pneumococcal vaccine. Pediatr Infect Dis J 2006; 25: 293-300.
18. Sociedad Española de Urgencias Pediátricas (SEUP). Indicadores pediátricos para medir los criterios de calidad de la atenciõn sanitaria. Available at: http://www.seup.org/pdf-public/gt/mejora-indicadores.pdf (accessed on February 20, 2014).
19. Segal GS, Chamberlain JM,. Resource utilization and contaminated blood cultures in children at risk for occult bacteraemia. Arch Pediatr Adolesc Med 2000; 154: 469-73.
20. Mintegi S, Benito J, Sánchez J, Azkunaga B, Iturralde I, García S,. Predictors of occult bacteraemia in young febrile children in the era of heptavalent pneumococcal conjugated vaccine. Eur J Emerg Med 2009; 16: 199-205.
21. Van den Bruel A, Thompson MJ, Haj-Hassan T, Stevens R, Moll H, Lakhanpaul M, et al. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review. BMJ 2011; 342: d3082.
22. Andreola B, Bressan S, Callegaro S, Liverani A, Plebani M, Da Dalt L,. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J 2007; 26: 672-7.
23. Fernández Lopez A, Luaces Cubells C, García García JJ, Fernández Pou J,; Spanish Society of Pediatric Emergencies. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a marker qualitative test for this marker. Pediatr Infect Dis J 2003; 22: 895-903.
24. Galetto-Lacour A, Zamora SA, Gervaix A,. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics 2003; 112: 1054-60.
25. Luaces-Cubells C, Mintegi S, García-García JJ, Astoccult Bacteraemiaiza E, Garrido-Romero R, Velasco-Rodríguez J, et al. Procalcitonin to detect invasive bacterial infection in non-toxic-appearing infants with fever without apparent source in the emergency department. Pediatr Infect Dis J 2012; 31: 645-7.
26. American Academy of Paediatrics, Committee on quality improvement and management, Subcommittee on Urinary Tract Infection. Urinary Tract Infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011; 128: 595-610.
27. Mintegi S, Benito J, Pijoan JI, Marañon R, Peñalba A, Gonzalez A, et al. Occult pneumonia in infants with high fever without source: a prospective multicenter study. Pediatr Emerg Care 2010; 26: 470-4.